Summary
Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.
HeyReport estimates that the Irritable Bowel Syndrome (IBS) market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx%. The base year considered for this report is 2019, and the market forecast is projected from 2021 to 2025.
In this report, HeyReport discusses the Global & USA industrial policies, economic environment, and the impact of covid-19 on the Irritable Bowel Syndrome (IBS)industry and its cost structure. Besides, this report covers the basic market dynamics, market size and companies competition data. In addition, the report also conducts basic market research on major product type, market end-use and regional trade.
Market Segment as follows:
Product Type Segmentation Includes
IBS-D Drug
IBS-C Drug
Others
Application Segmentation Includes
Women
Men
Companies Includes
Valeant Pharmaceuticals
Allergan
Takeda
Sucampo Pharmaceuticals
McNeil Consumer Healthcare
Sebela Pharmaceuticals
Astellas Pharmaceuticals
IM HealthScience
The main contents of the report including:
Section 1:
Product definition, type and application, Global & USA market overview;
Section 2:
Global & USA Market competition by company;
Section 3:
Global & USA sales revenue, volume and price by type;
Section 4:
Global & USA sales revenue, volume and price by application;
Section 5:
USA export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
Industrial policies & economic environment
Section 9:
Conclusion.
For any other requirements, please feel free to contact HeyReport for customized contents.
Table of Contents
1 Market Overview
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 IBS-D Drug
1.1.2.2 IBS-C Drug
1.1.2.3 Others
1.1.3 Market by Application
1.1.3.1 Women
1.1.3.2 Men
1.2 Global & USA Market Size & Forecast
1.2.1 Global Market (2015-2020 & 2021-2026)
1.2.2 USA Market (2015-2020 & 2021-2026)
2 Global & USA Market by Company
2.1 Global Sales by Company
2.2 USA Sales by Company
3 Global & USA Market by Type
3.1 Global Sales by Product Type
3.2 USA Sales by Product Type
4 Global & USA Market by Application
4.1 Global Sales by Application
4.2 USA Sales by Application
5 USA Trade
5.1 Export Overview
5.2 Import Overview
6 Key Companies List
6.1 Valeant Pharmaceuticals
6.1.1 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Allergan
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Takeda
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 Sucampo Pharmaceuticals
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 McNeil Consumer Healthcare
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Sebela Pharmaceuticals
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Astellas Pharmaceuticals
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 IM HealthScience
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
7 Industry Upstream
7.1 Industry Chain
7.2 Upstream Overview
8 Policies & Market Environment
8.1 Policies
8.1.1 Major Regions Policies
8.1.2 Policies in USA
8.2 Market Environment
8.2.1 Porter's Five Forces
8.2.2 Impact of COVID-19
9 Research Conclusion
Market Overview
The Asia Pacific Oxygen Therapy Equipment Market is anticipated to experience significant growth from 2024 to 2034, driven by rising incidences of respiratory diseases, increasing geriatric population, and advancements in healthcare technology. The market is projected to...
Market Overview
The Europe Oxygen Therapy Equipment Market is anticipated to experience significant growth over the next decade, driven by advancements in medical technology, increasing prevalence of respiratory diseases, and a growing aging population. The market is expected to reach a...
Market Overview
The North America Oxygen Therapy Equipment Market is anticipated to experience significant growth from 2024 to 2034. This growth will be driven by a rise in respiratory diseases, technological advancements in oxygen therapy equipment, and an increasing emphasis on home h...
Market Overview
The Global Oxygen Therapy Equipment Market is anticipated to experience robust growth over the next decade, propelled by the rising prevalence of respiratory diseases, increasing geriatric population, and advancements in medical technology. In 2024, the market is valued ...
The Acute Respiratory Distress Syndrome (ARDS) Treatment Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, compe...
The Polycystic Ovary Syndrome (PCOS) Treatment Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lan...
Executive Summary
Azoth Analytics has released a research report titled "Global Irritable Bowel Disease Market (2024 Edition)" which provides a complete analysis of the Global Irritable Bowel Disease industry in terms of market segmentation By Drug Class (Corticosteroids, JAK inhibitors...
Overview of the Global Polycystic Ovary Syndrome (PCOS) Blood Test Market:
The report discusses everything a marketer requires before investing in the global Polycystic Ovary Syndrome (PCOS) Blood Test Market during...
The global Polycystic Ovary Syndrome Treatment market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market ...
The global Polycystic Ovary Syndrome (PCOS) Drugs market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help mark...